← Evidence map

TrialThe lancet. Diabetes & endocrinology2021

Testosterone treatment to prevent or revert type 2 diabetes in men enrolled in a lifestyle programme (T4DM): a randomised, double-blind, placebo-controlled, 2-year, phase 3b trial.

Gary Wittert et al.PubMed ↗Publisher ↗

No numbers read from the abstract.

139 papers cite itlatest 60 shown

2021
2022
2023
2024
2025
2026
this paperpooled ittrialcites it
Full record →Abstract, authors, funding and every citing paper · PMID 33338415